mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |